Metamucil Kalorienarm Orange

Psyllium husk, the active ingredient in Metamucil Kalorienarm Orange, is a bulk-forming laxative presented as a powder for oral use. It increases stool bulk and water content, helping to relieve occasional constipation and support regular bowel movements in adults.\n\nGNH India supplies Metamucil Kalorienarm Orange as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Metamucil Kalorienarm Orange, a bulk‑forming laxative, is used to manage conditions related to intestinal transit and dietary fiber deficiency.\n\n- Constipation: helps soften stool and promote regular bowel movements.\n- Bowel regularity: provides supplemental dietary fiber to maintain normal stool frequency.\n- Dietary fiber supplementation: supports overall gut health and may aid in managing mild digestive discomfort.

Metamucil Kalorienarm Orange is generally well tolerated, but some users may experience mild adverse reactions.\n\nCommon Side Effects:\n- Abdominal bloating\n- Flatulence\n- Mild abdominal cramping\n- Nausea\n- Diarrhea when taken in excess\n- Increased stool frequency\n\nSerious or Rare Side Effects:\n- Intestinal blockage, especially if insufficient fluid is consumed\n- Severe allergic reaction (anaphylaxis)\n- Rectal bleeding\n- Persistent severe abdominal pain\n- Swelling of the throat or tongue

When using Metamucil Kalorienarm Orange, consider the following safety measures.\n\n- Adequate fluid intake: consume plenty of water with each dose to prevent choking or blockage.\n- Gradual dose escalation: start with a low amount and increase slowly to minimize gastrointestinal discomfort.\n- Monitor for abdominal pain: discontinue if severe or persistent pain occurs.\n- Known hypersensitivity: avoid if you have a documented allergy to psyllium or related fibers.\n- Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Psyllium husk may affect the absorption of certain medications; consider the following interaction guidance.\n\nMajor Interactions (Avoid):\n- Antidiabetic agents: may alter glucose absorption, requiring close monitoring.\n- Lithium: reduced absorption may lead to sub‑therapeutic levels.\n\nModerate Interactions (Monitor Closely):\n- Thyroid hormone replacement: may decrease absorption; separate dosing by at least 2 hours.\n- Iron supplements: psyllium can reduce iron uptake; separate dosing by 2 hours.\n- Tetracycline or quinolone antibiotics: may have reduced bioavailability; separate dosing by 2 hours.